Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease
- PMID: 17374405
- DOI: 10.1016/j.bbr.2007.01.028
Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease
Abstract
In rodent models of Parkinson's disease (PD), exercise or complex living environments introduced immediately before or during early stages of degeneration can provide beneficial effects on functional and/or neurochemical outcome. The goal of this study was to determine whether or not exposure to repetitive vibrissae-elicited forelimb placing, a dopamine-dependent sensorimotor movement, improves functional outcome in rats infused unilaterally with 6-OHDA. Prior to unilateral 6-OHDA infusions into the medial forebrain bundle, male Sprague-Dawley rats were randomly divided into groups exposed to one of five placing schedules: (1) two consecutive days pre-6-OHDA (PRE), (2) PRE+day 1 post-6-OHDA, (3) PRE+days 1, 2, 3 post-6-OHDA, (4) HANDLE, and (5) Sham infusion+handle. A session consisted of 180 total trials (90 left forelimb and 90 right forelimb trials) including 60 consecutive trials where vibrissae stimulation evoked ipsilateral forelimb movement and 30 consecutive trials where the ipsilateral forelimb was restrained so that vibrissae evoked contralateral forelimb movement (cross-midline placing). All groups were exposed to forelimb placing sessions on post-infusion days 7 and 14. The ability of vibrissae stimulation to elicit an ipsilateral response of the 6-OHDA affected forelimb was assessed on all days. Animals were sacrificed on post-lesion day 15 and substantia nigra tyrosine hydroxylase immunoreactivity (TH-ir) quantified. Repetitive forelimb placing had a significant effect on behavioral performance for all groups compared to the HANDLE group, but only the PRE+123 group was not significantly different from SHAM controls. Only the PRE+123 group showed significant sparing of TH-ir compared to the HANDLE group. These data suggest that extensive repetitive exposure to a sensorimotor task may provide therapeutic effects in an animal model of PD.
Similar articles
-
Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats.Exp Neurol. 2005 Feb;191(2):310-7. doi: 10.1016/j.expneurol.2004.09.005. Exp Neurol. 2005. PMID: 15649486
-
Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model.Behav Brain Res. 2010 Jun 26;210(1):46-53. doi: 10.1016/j.bbr.2010.02.003. Epub 2010 Feb 6. Behav Brain Res. 2010. PMID: 20138919
-
High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.Neuroscience. 2007 Sep 7;148(3):815-23. doi: 10.1016/j.neuroscience.2007.06.043. Epub 2007 Jul 17. Neuroscience. 2007. PMID: 17706885
-
Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.Exp Neurol. 2002 Jun;175(2):303-17. doi: 10.1006/exnr.2002.7891. Exp Neurol. 2002. PMID: 12061862 Review.
-
Marmoset monkey models of Parkinson's disease: which model, when and why?Brain Res Bull. 2005 Dec 30;68(3):140-9. doi: 10.1016/j.brainresbull.2005.08.005. Epub 2005 Sep 7. Brain Res Bull. 2005. PMID: 16325013 Review.
Cited by
-
Nanoparticle transport across the blood brain barrier.Tissue Barriers. 2016 Feb 25;4(1):e1153568. doi: 10.1080/21688370.2016.1153568. eCollection 2016 Jan-Mar. Tissue Barriers. 2016. PMID: 27141426 Free PMC article. Review.
-
A working model for the assessment of disruptions in social behavior among aged rats: The role of sex differences, social recognition, and sensorimotor processes.Exp Gerontol. 2016 Apr;76:46-57. doi: 10.1016/j.exger.2016.01.012. Epub 2016 Jan 23. Exp Gerontol. 2016. PMID: 26811912 Free PMC article.
-
Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.Brain Res. 2011 Mar 25;1382:315-20. doi: 10.1016/j.brainres.2011.01.061. Epub 2011 Jan 26. Brain Res. 2011. PMID: 21276430 Free PMC article.
-
Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy.Pharm Res. 2009 May;26(5):1059-63. doi: 10.1007/s11095-008-9815-9. Epub 2008 Dec 23. Pharm Res. 2009. PMID: 19104914
-
Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport.Front Aging Neurosci. 2023 Nov 13;15:1276376. doi: 10.3389/fnagi.2023.1276376. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38035276 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources